When was Amylyx Pharmaceuticals, Inc. stock made available for the first time to the public?

The IPO Date for Amylyx Pharmaceuticals, Inc. is 2022-01-07. On this 2022-01-07, Amylyx Pharmaceuticals, Inc. stock was made publicly available.

Where is the headquarters of Amylyx Pharmaceuticals, Inc. stock?

Headquarters of Amylyx Pharmaceuticals, Inc. is in US at 43 Thorndike Street, Cambridge, MA 02141.

What industry does Amylyx Pharmaceuticals, Inc. belong to?

The Amylyx Pharmaceuticals, Inc. belongs to Biotechnology.

Amylyx Pharmaceuticals, Inc.

AMLX•NASDAQ

Healthcare

Biotechnology

$7.68

$0.29(3.92%)

Amylyx Pharmaceuticals, Inc. (AMLX) Company Profile & Overview

Explore Amylyx Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Amylyx Pharmaceuticals, Inc. (AMLX) Company Profile & Overview

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

SectorHealthcare

IndustryBiotechnology

CEOJoshua B. Cohen

Contact Information

https://amylyx.com

617 682 0917

43 Thorndike Street, Cambridge, MA, 02141

Company Facts

123 Employees

IPO DateJan 7, 2022

CountryUS

Actively Trading

Frequently Asked Questions

;